Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
Sio Gene Therapies Inc. (AXON)
| Date | Name | Title | Type | Security | Shares | Price | Value | Ownership | Reported |
| 02/08/2022 | Meswani Parag V | Chief Commercial Officer | Grant | Restricted Stock Units | 153.7k | $0.00 | $0 | | 02/08/2022 |
| 02/08/2022 | Nassif David W. | Interim CEO, CFO | Grant | Restricted Stock Units | 546.5k | $0.00 | $0 | | 02/08/2022 |
| 12/08/2021 | Nassif David W. | Interim CEO, CFO | Grant | Common Stock | 17.5k | $0.00 | $0 | | 12/08/2021 |
| 12/08/2021 | Nassif David W. | Interim CEO, CFO | Payment of Exercise | Common Stock | 6.3k | $1.42 | $8.9k | | 12/08/2021 |
| 12/08/2021 | Nassif David W. | Interim CEO, CFO | Disposition | Restricted Stock Units | 17.5k | $0.00 | $0 | | 12/08/2021 |
| 12/08/2021 | Cheruvu Pavan | CEO | Grant | Common Stock | 37.6k | $0.00 | $0 | | 12/08/2021 |
| 12/08/2021 | Cheruvu Pavan | CEO | Payment of Exercise | Common Stock | 14.9k | $1.42 | $21.1k | | 12/08/2021 |
| 12/08/2021 | Cheruvu Pavan | CEO | Disposition | Restricted Stock Units | 37.6k | $0.00 | $0 | | 12/08/2021 |
| 04/15/2021 | Corcoran Gavin | Chief R&D Officer | Grant | Stock Option (Right to Buy) | 244.3k | $2.47 | $603.4k | | 04/15/2021 |
| 04/15/2021 | Vuori Kristiina MD | Director | Grant | Stock Option (Right to Buy) | 42k | $2.47 | $103.7k | | 04/15/2021 |
| 04/15/2021 | Nassif David W. | Interim CEO, CFO | Grant | Stock Option (Right to Buy) | 239k | $2.47 | $590.3k | | 04/15/2021 |
| 04/15/2021 | Pande Atul | Director | Grant | Stock Option (Right to Buy) | 42k | $2.47 | $103.7k | | 04/15/2021 |
| 04/15/2021 | Modig Berndt | Director | Grant | Stock Option (Right to Buy) | 42k | $2.47 | $103.7k | | 04/15/2021 |
| 04/15/2021 | Sundaram Senthil Vel | Director | Grant | Stock Option (Right to Buy) | 42k | $2.47 | $103.7k | | 04/15/2021 |
| 04/15/2021 | Torti Frank | Director | Grant | Stock Option (Right to Buy) | 42k | $2.47 | $103.7k | | 04/15/2021 |
| 04/15/2021 | Cheruvu Pavan | CEO | Grant | Stock Option (Right to Buy) | 682.1k | $2.47 | $1.7M | | 04/15/2021 |
| 03/23/2021 | Cheruvu Pavan | CEO | Purchase | Common Stock | 100k | $2.48 | $248.2k | | 03/23/2021 |
| 03/22/2021 | Nassif David W. | Interim CEO, CFO | Grant | Common Stock | 15.1k | $0.00 | $0 | | 03/22/2021 |
| 03/22/2021 | Nassif David W. | Interim CEO, CFO | Disposition | Restricted Stock Units | 15.1k | $0.00 | $0 | | 03/22/2021 |
| 03/17/2021 | Cheruvu Pavan | CEO | Grant | Common Stock | 22.6k | $0.00 | $0 | | 03/17/2021 |
| 03/17/2021 | Cheruvu Pavan | CEO | Disposition | Restricted Stock Units | 22.6k | $0.00 | $0 | | 03/17/2021 |
| 03/17/2021 | Corcoran Gavin | Chief R&D Officer | Grant | Common Stock | 16k | $0.00 | $0 | | 03/17/2021 |
| 03/17/2021 | Corcoran Gavin | Chief R&D Officer | Disposition | Restricted Stock Units | 16k | $0.00 | $0 | | 03/17/2021 |
| 11/24/2020 | Pande Atul | Director | Purchase | Common Stock | 10k | $2.34 | $23.4k | By Atul C. Pande and Patricia A Pande TR DTD 08/24/2017 | 11/24/2020 |
| 10/05/2020 | Vuori Kristiina MD | Director | Grant | Stock Option (Right to Buy) | 35k | $5.63 | $197k | | 10/05/2020 |
| 07/08/2020 | Pande Atul | Director | Purchase | Common Shares | 10k | $2.73 | $27.3k | By Atul C. Pande & Patricia A Pande TR DTD 08/24/2017 | 07/08/2020 |
| 07/08/2020 | Cheruvu Pavan | CEO | Purchase | Common Shares | 37.5k | $2.74 | $102.6k | | 07/08/2020 |
| 06/12/2020 | Corcoran Gavin | Chief R&D Officer | Grant | Common Shares | 16k | $0.00 | $0 | | 06/12/2020 |
| 06/12/2020 | Corcoran Gavin | Chief R&D Officer | Payment of Exercise | Common Shares | 6.2k | $3.46 | $21.5k | | 06/12/2020 |
| 06/12/2020 | Corcoran Gavin | Chief R&D Officer | Disposition | Restricted Stock Units | 16k | $0.00 | $0 | | 06/12/2020 |
| 06/12/2020 | Nassif David W. | Interim CEO, CFO | Disposition | Restricted Stock Units | 15.1k | $0.00 | $0 | | 06/15/2020 |
| 06/11/2020 | Cheruvu Pavan | CEO | Grant | Common Shares | 22.6k | $0.00 | $0 | | 06/11/2020 |
| 06/11/2020 | Nassif David W. | Interim CEO, CFO | Grant | Common Shares | 15.1k | $0.00 | $0 | | 06/15/2020 |
| 06/11/2020 | Nassif David W. | Interim CEO, CFO | Payment of Exercise | Common Shares | 5.3k | $3.25 | $17.1k | | 06/15/2020 |
| 06/11/2020 | Cheruvu Pavan | CEO | Payment of Exercise | Common Shares | 9.8k | $3.09 | $30.1k | | 06/11/2020 |
|
|